Stock Events

Stock Events

Kalaris Therapeutics (KLRS) Q2 2025 Earnings

14MayConfirmed

Q1 2025

Q2 2025

-7.34

-5.15

-2.96

-0.78

Details

Expected EPS

-0.775

Actual EPS

-2.52

Surprise EPS

-1.75

Surprise Percent

+225.16%

Description

Kalaris Therapeutics (KLRS) has reported earnings of -2.52 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.